...
首页> 外文期刊>Biochemistry >11#beta#-Hydroxysteroid Dehydrogenase Type 1 from Human Liver: Dimerization and Enzyme Cooperativity Support Its Postulated Role as Glucocorticoid Reductase
【24h】

11#beta#-Hydroxysteroid Dehydrogenase Type 1 from Human Liver: Dimerization and Enzyme Cooperativity Support Its Postulated Role as Glucocorticoid Reductase

机译:来自人类肝脏的11#beta#-羟基类固醇脱氢酶1:二聚化和酶协同作用支持其假定的糖皮质激素还原酶作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

11#beta#-Hydroxysteropid dehydrogenase type 1 (11#beta#-HSD 1) is a microsomal enzyme that catalyzes the reversible interconversion of receptor-active 11-hydroxy glucocorticoids (cortisol) to their receptorinactive 11-oxo metabolites (cortisone). However, the physiological role of 11#beta#-HSD 1 as prereceptor control device in regulating access of glucocorticoid hormones to the glucocorticoid receptor remains obscure in light of its low substrate affinities, which is in contrast to low glucocorticoid plasma levels and low K_d values of the receptors to cortisol. To solve this enigma, we performed detailed kinetic analyses with a homogeneously purified 11#beta#-HSD 1 from human liver. The membrane-bound enzyme was successfully obtained in an active state by a purification procedure that took advantage of gentle solubilization method as well as providing a favorable detergent surrounding during the various chromatographic steps. The identity of purified 11#beta#-HSD 1 was proven by determination of enzymatic activity, N-terminal amino acid sequencing, and immunoblot analysis. By gel-permeation chromatography we could demonstrate that 11#beta#-HSD 1 is active as a dimeric enzyme. The cDNA for the enzyme was cloned from a human liver cDNA library and shown to be homologous to that previously characterized in human testis. Interestingly, 11#beta#-HSD 1 exhibits Michaelis-Menten kinetics with cortisol and corticosterone (11#beta#-dehydrogenation activity) but cooperative kinetics with cortisone and dehydrocorti-costerone (11-oxoreducing activity). Accordingly, this enzyme dynamically adapts to low (nanomolar) as well as to high (micromolar) substrate concentrations, thereby providing the fine-tuning required as a consequence of great variations in circadian plasma glucocorticoid levels.
机译:11#beta#-羟基甾类脱氢酶1(11#beta#-HSD 1)是一种微粒体酶,可催化受体活性11-羟基糖皮质激素(皮质醇)可逆转换为它们的受体非活性11-氧代代谢产物(可的松)。然而,由于其底物亲和力低,因此11#beta#-HSD 1作为前体控制装置在调节糖皮质激素激素进入糖皮质激素受体中的生理作用仍然不清楚,这与糖皮质激素血浆水平低和K_d值低相反皮质醇的受体。为了解决这个难题,我们使用了来自人肝脏的均匀纯化的11#beta#-HSD 1进行了详细的动力学分析。通过利用温和的增溶方法以及在各个色谱步骤中提供良好的去污剂的纯化程序,可以成功地以活化状态获得膜结合酶。纯化的11#beta#-HSD 1的身份通过确定酶活性,N端氨基酸测序和免疫印迹分析得到了证实。通过凝胶渗透色谱,我们可以证明11#beta#-HSD 1作为二聚酶具有活性。该酶的cDNA是从人肝cDNA文库中克隆的,与先前在人睾丸中鉴定的同源。有趣的是,11#beta#-HSD 1表现出具有皮质醇和皮质酮的Michaelis-Menten动力学(11#beta#-脱氢活性),但具有可的松和脱氢皮质甾酮(11-氧化还原活性)的协同动力学。因此,该酶动态地适应于低(纳摩尔)以及高(微摩尔)底物浓度,从而由于昼夜节律血浆糖皮质激素水平的巨大变化而提供了所需的微调。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号